SCREENS for Cancer Act of 2025
- Sponsor
- Rep. Morelle, Joseph D. [D-NY-25]
- Committees
- Energy and Commerce Committee (primary)
- Last action
- Mar 26, 2025
Bottom line
This bill reauthorizes and strengthens a critical public health program aimed at early detection and prevention of breast and cervical cancers for underserved populations, with a significant financial commitment and a focus on health equity.
What it actually does
This bill reauthorizes the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) for fiscal years 2026 through 2030, authorizing $235,000,000 annually. It expands the program's purpose to explicitly include prevention, enhancing support activities for screening, reducing disparities, and improving equitable access. The bill also mandates a Government Accountability Office (GAO) study on the program's effectiveness and reach.
Proponents argue
Supporters argue that the NBCCEDP has been a highly successful, life-saving program, as evidenced by the millions served and cancers detected. Reauthorizing and expanding its scope to include prevention, enhanced navigation, and explicit disparity reduction will further improve public health outcomes, especially for low-income, uninsured, and underinsured women, leading to more cancers diagnosed at earlier, more treatable stages.
Opponents contend
No specific opposition is typically raised against the reauthorization of established public health programs like NBCCEDP, which have a proven track record of positive health outcomes. Potential criticisms, if any, might revolve around the level of funding authorized or the administrative burden of new reporting requirements, but these are not explicitly stated in the bill's context.
The bill is concise and clearly written, making it accessible for an informed reader to understand its provisions and implications within a short timeframe.
Section 3(4) amending Section 1510(a) of the Public Health Service Act
Reauthorization of Appropriations for NBCCEDP
This provision reauthorizes funding for the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) at $235,000,000 annually for fiscal years 2026 through 2030. This ensures the program has the financial resources to continue its operations and expand its services over the next five years, maintaining its critical role in public health.
Supporters argue
Supporters contend that consistent and increased funding is essential to maintain and expand the NBCCEDP's life-saving services, especially given rising healthcare costs and the ongoing need to reach underserved populations. The authorized amount reflects a commitment to public health and early cancer detection.
Critics contend
No specific opposition is typically raised against funding for cancer screening programs. Potential concerns, if any, might focus on the overall federal budget or competing priorities, rather than the program's merit itself.
Tradeoffs
The primary tension is balancing the significant public health benefits of early cancer detection against the overall federal budget constraints. The bill prioritizes public health investment in this area.
Section 3(1) amending Section 1501(a) of the Public Health Service Act
Enhanced Program Scope for Prevention, Equity, and Support
This provision expands the stated purpose of the NBCCEDP to explicitly include "prevention" alongside detection and control. It also adds new objectives: enhancing support activities like health care navigation and evidence-based screening strategies, reducing disparities in cancer incidence and deaths, and improving equitable access to services by addressing related barriers.
Section 3(2) amending Section 1503(a) and Section 3(3) amending Section 1508(b) of the Public Health Service Act
Modernized Grant Conditions and Reduced Reporting Frequency
This provision streamlines the requirements for grants for screening and follow-up services, removing some specific initial conditions and paragraphs, while maintaining the focus on evidence-based recommendations. It also significantly reduces the frequency of reports to Congress from annually to every five years (after an initial two-year report), updating the relevant committee name.
The bill strikes subsection (d) of section 1501 of the Public Health Service Act. Historically, this subsection stated that nothing in the section should be construed to establish a right to cancer screening or treatment.
Section 3(1)(B) striking subsection (d) of Section 1501 (42 U.S.C. 300k)
Why it matters:While striking a subsection is a standard legislative action, the full impact of removing a "rule of construction" might not be immediately apparent without knowing the original text. It could be seen as a technical cleanup or a subtle policy shift.
Case for: Proponents might argue that removing this language aligns with the bill's broader goal of improving equitable access and reducing barriers, as it removes a statutory disclaimer that could be perceived as limiting the program's commitment to providing services. It could implicitly strengthen the program's mandate to ensure services are provided.
Case against: Opponents might argue that the original "rule of construction" served to clarify the program's scope and prevent misinterpretations regarding individual entitlements, and its removal could create ambiguity or unintended legal implications regarding the nature of the services provided.
Estimated impact: The direct impact is legal/interpretive, potentially influencing how the program's obligations are understood. It does not directly create a new right but removes a disclaimer against one.